Dr. Basho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8700 Beverly Blvd
West Hollywood, CA 90048Phone+1 310-967-2700
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2010 - 2013
Baylor College of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2011 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers Start of enrollment: 2021 Sep 09
Roles: Principal Investigator
Publications & Presentations
PubMed
- 13 citationsSingle-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer.Stephen L Shiao, Kenneth H Gouin 3rd, Nathan Ing, Alice Ho, Reva Basho
Cancer Cell. 2024-01-08 - 124 citationsCOVID-19 in cancer patients: risk, clinical features, and management.Cuiwei Liu, Yanxia Zhao, Derick Okwan-Duodu, Reva Basho, Xiaojiang Cui
Cancer Biology & Medicine. 2020-08-15 - 33 citationsLongitudinal SARS-CoV-2 mRNA vaccine-induced humoral immune responses in cancer patients.Jane C. Figueiredo, Noah Merin, Omid Hamid, So Yung Choi, Tucker Lemos
Cancer Research. 2021-11-10
Press Mentions
Cedars-Sinai and Torrance Memorial Mark Four Years of AffiliationFebruary 9th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
